Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2024 Earnings Call Transcript

Page 4 of 4

Thomas Yip: Understood. Thank you, again, for taking our questions. We look forward to CHMP recommendation soon and also your June presentation for volixibat.

Chris Peetz: Sounds good. Thanks, Thomas.

Operator: We have no further questions. Therefore, I will hand back the call to Chris Peetz, CEO, for final remarks.

Chris Peetz: Great. Thank you all for joining us today. Really appreciate the interest in Mirum and our programs. Have a good evening. Goodbye.

Operator: This concludes today’s conference call. Thank you all for joining. You may now disconnect your lines.

Follow Mirum Pharmaceuticals Inc. (NASDAQ:MIRM)

Page 4 of 4